Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R M Zusman

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Annual Review of Medicine|January 1, 1981
Prostaglandins and water excretionR M Zusman
American Journal of Hypertension|January 5, 2000
Are there differences among angiotensin receptor blockers?R M Zusman
International Journal of Clinical Practice|April 6, 2000
The role of alpha 1-blockers in combination therapy for hypertensionR M Zusman
Prostaglandins|February 1, 1972
Quantitative conversion of PGA or PGE to PGBR M Zusman
Clinical Research|April 1, 1989
On the occasion of the fiftieth anniversary of the founding of the American Federation for Clinical Research. A look to the futureR M Zusman
American Journal of Hypertension|June 1, 1989
Left ventricular function in hypertension. Relevance to the selection of antihypertensive therapyR M Zusman
Managed Care (Langhorne, Pa.)|December 4, 2001
Antiplatelet therapy: a perspective from cardiologyR M Zusman
Managed Care (Langhorne, Pa.)|December 4, 2001
Clinical and economic implications of atherosclerosisR M Zusman
The Medical Clinics of North America|July 1, 1981
Prostaglandins, vasopressin, and renal water reabsorptionR M Zusman
Managed Care (Langhorne, Pa.)|December 4, 2001
Antiplatelet therapy: a perspective from cardiologyR M Zusman
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Annual Review of Medicine|January 1, 1981
Prostaglandins and water excretionR M Zusman
American Journal of Hypertension|January 5, 2000
Are there differences among angiotensin receptor blockers?R M Zusman
International Journal of Clinical Practice|April 6, 2000
The role of alpha 1-blockers in combination therapy for hypertensionR M Zusman
Prostaglandins|February 1, 1972
Quantitative conversion of PGA or PGE to PGBR M Zusman
Clinical Research|April 1, 1989
On the occasion of the fiftieth anniversary of the founding of the American Federation for Clinical Research. A look to the futureR M Zusman
American Journal of Hypertension|June 1, 1989
Left ventricular function in hypertension. Relevance to the selection of antihypertensive therapyR M Zusman
Managed Care (Langhorne, Pa.)|December 4, 2001
Antiplatelet therapy: a perspective from cardiologyR M Zusman
Managed Care (Langhorne, Pa.)|December 4, 2001
Clinical and economic implications of atherosclerosisR M Zusman
The Medical Clinics of North America|July 1, 1981
Prostaglandins, vasopressin, and renal water reabsorptionR M Zusman
Managed Care (Langhorne, Pa.)|December 4, 2001
Antiplatelet therapy: a perspective from cardiologyR M Zusman
Pageof 8